Michael Weintraub

3.6k total citations · 1 hit paper
92 papers, 2.4k citations indexed

About

Michael Weintraub is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Michael Weintraub has authored 92 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 19 papers in Hematology. Recurrent topics in Michael Weintraub's work include Acute Myeloid Leukemia Research (8 papers), Neuroblastoma Research and Treatments (8 papers) and Renal and related cancers (8 papers). Michael Weintraub is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Neuroblastoma Research and Treatments (8 papers) and Renal and related cancers (8 papers). Michael Weintraub collaborates with scholars based in Israel, United States and United Kingdom. Michael Weintraub's co-authors include Shoshana Revel‐Vilk, Polina Stepensky, Orly Elpeleg, Matthew Truong, Srinivas Vourganti, Lambros Stamatakis, Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Maria J. Merino and Barış Türkbey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Weintraub

89 papers receiving 2.3k citations

Hit Papers

Magnetic Resonance Imaging/Ultrasound–Fusion Biopsy Signi... 2013 2026 2017 2021 2013 100 200 300

Peers

Michael Weintraub
J R Salisbury United Kingdom
David Gillis Australia
Stefan Meyer United Kingdom
LoAnn Peterson United States
J R Salisbury United Kingdom
Michael Weintraub
Citations per year, relative to Michael Weintraub Michael Weintraub (= 1×) peers J R Salisbury

Countries citing papers authored by Michael Weintraub

Since Specialization
Citations

This map shows the geographic impact of Michael Weintraub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weintraub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weintraub more than expected).

Fields of papers citing papers by Michael Weintraub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Weintraub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weintraub. The network helps show where Michael Weintraub may publish in the future.

Co-authorship network of co-authors of Michael Weintraub

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Weintraub. A scholar is included among the top collaborators of Michael Weintraub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Weintraub. Michael Weintraub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picarsic, Jennifer, Theodore J. Pysher, Holly Zhou, et al.. (2019). BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathologica Communications. 7(1). 168–168. 36 indexed citations
2.
Stepensky, Polina, Baerbel Keller, Oded Shamriz, et al.. (2016). Deep intronic mis-splicing mutation in JAK3 gene underlies T − B + NK − severe combined immunodeficiency phenotype. Clinical Immunology. 163. 91–95. 13 indexed citations
3.
Ben‐Ami, Tal, Shoshana Revel‐Vilk, Rebecca Brooks, et al.. (2016). Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency. The Journal of Pediatrics. 177. 316–320. 64 indexed citations
4.
Shamriz, Oded, Diana Averbuch, Reuven Or, et al.. (2015). Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies. Journal of Pediatric Hematology/Oncology. 37(5). e295–e300. 11 indexed citations
5.
Ben‐Ami, Tal, et al.. (2015). Ewing Sarcoma. Journal of Pediatric Hematology/Oncology. 38(1). 38–42. 5 indexed citations
6.
Li, Qingdi Quentin, Huiping Zhou, Yinying Lu, et al.. (2014). Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Medical Oncology. 31(7). 14–14. 16 indexed citations
7.
Stepensky, Polina, Aviva C. Krauss, Gal Goldstein, et al.. (2013). Impact of Conditioning on Outcome of Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome. Journal of Pediatric Hematology/Oncology. 35(6). e234–e238. 10 indexed citations
8.
Tamir, Idit, et al.. (2012). Solitary juvenile xanthogranuloma mimicking intracranial tumor in children. Journal of Clinical Neuroscience. 20(1). 183–188. 21 indexed citations
9.
Revel‐Vilk, Shoshana, Diana Averbuch, Hadas Mechoulam, et al.. (2011). Congenital cytomegalovirus infection and Wiskott–Aldrich syndrome successfully treated with unrelated cord blood transplantation. Pediatric Blood & Cancer. 57(4). 681–683. 6 indexed citations
10.
Revel‐Vilk, Shoshana, et al.. (2010). Post‐thrombotic syndrome after central venous catheter removal in childhood cancer survivors is associated with a history of obstruction. Pediatric Blood & Cancer. 55(1). 153–156. 17 indexed citations
11.
Revel‐Vilk, Shoshana, Joanne Yacobovich, Hannah Tamary, et al.. (2010). Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer. 116(17). 4197–4205. 92 indexed citations
12.
Varon, D., Ela Shai, Yoram Agmon, et al.. (2009). Evaluation of children with a suspected bleeding disorder applying the Impact‐R [Cone and Plate(let) Analyzer]. Journal of Thrombosis and Haemostasis. 7(12). 1990–1996. 5 indexed citations
13.
Weintraub, Michael, et al.. (2007). Brain mast cell relationship to neurovasculature during development. Brain Research. 1171. 18–29. 96 indexed citations
14.
Amir, Gail & Michael Weintraub. (2007). Association of cell cycle‐related gene products and NF‐kappaB with clinical parameters in Langerhans cell histiocytosis. Pediatric Blood & Cancer. 50(2). 304–307. 20 indexed citations
15.
Weintraub, Michael, Eitan Gross, Avishag Kadari, et al.. (2006). Should ovarian cryopreservation be offered to girls with cancer. Pediatric Blood & Cancer. 48(1). 4–9. 31 indexed citations
16.
Waldman, Dalia, Michael Weintraub, Arnold I. Freeman, et al.. (2004). Favorable early response of secondary chronic myeloid leukemia to imatinib. American Journal of Hematology. 75(4). 217–219. 4 indexed citations
17.
Weintraub, Michael, et al.. (2000). Spontaneous regression of congenital leukaemia with an 8;16 translocation. SHORT REPORT. British Journal of Haematology. 111(2). 641–643. 16 indexed citations
18.
Weintraub, Michael, Kishor Bhatia, Roma Chandra, Ian Magrath, & Stephan Ladisch. (1998). p53 Expression in Langerhans Cell Histiocytosis. Journal of Pediatric Hematology/Oncology. 20(1). 12–17. 41 indexed citations
19.
Weintraub, Michael, Magdalena Adde, D Venzon, et al.. (1996). Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.. Journal of Clinical Oncology. 14(3). 935–940. 39 indexed citations
20.
Rubio, Andres Carmona & Michael Weintraub. (1992). Scoring system in a pilot effectiveness study of patients with sickle cell anemia. 6(1). 47–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026